Trade Aytu BioScience, Inc. - AYTU CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.062 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023457% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001235% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.254 |
| Open | 1.244 |
| 1-Year Change | -56.29% |
| Day's Range | 1.214 - 1.274 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 26, 2025 | 1.254 | 0.030 | 2.45% | 1.224 | 1.274 | 1.224 |
| Feb 25, 2025 | 1.254 | -0.030 | -2.34% | 1.284 | 1.294 | 1.244 |
| Feb 24, 2025 | 1.284 | -0.060 | -4.46% | 1.344 | 1.344 | 1.284 |
| Feb 21, 2025 | 1.314 | -0.050 | -3.67% | 1.364 | 1.364 | 1.314 |
| Feb 20, 2025 | 1.354 | 0.030 | 2.27% | 1.324 | 1.384 | 1.304 |
| Feb 19, 2025 | 1.354 | -0.020 | -1.46% | 1.374 | 1.394 | 1.334 |
| Feb 18, 2025 | 1.364 | 0.000 | 0.00% | 1.364 | 1.394 | 1.344 |
| Feb 14, 2025 | 1.364 | -0.020 | -1.45% | 1.384 | 1.404 | 1.294 |
| Feb 13, 2025 | 1.354 | -0.020 | -1.46% | 1.374 | 1.414 | 1.334 |
| Feb 12, 2025 | 1.364 | -0.050 | -3.54% | 1.414 | 1.414 | 1.344 |
| Feb 11, 2025 | 1.404 | -0.030 | -2.09% | 1.434 | 1.484 | 1.404 |
| Feb 10, 2025 | 1.424 | -0.070 | -4.69% | 1.494 | 1.494 | 1.394 |
| Feb 7, 2025 | 1.524 | 0.010 | 0.66% | 1.514 | 1.554 | 1.484 |
| Feb 6, 2025 | 1.634 | 0.090 | 5.83% | 1.544 | 1.654 | 1.544 |
| Feb 5, 2025 | 1.624 | 0.040 | 2.53% | 1.584 | 1.634 | 1.544 |
| Feb 4, 2025 | 1.574 | 0.030 | 1.94% | 1.544 | 1.604 | 1.484 |
| Feb 3, 2025 | 1.604 | 0.030 | 1.91% | 1.574 | 1.604 | 1.564 |
| Jan 31, 2025 | 1.644 | 0.050 | 3.14% | 1.594 | 1.654 | 1.594 |
| Jan 30, 2025 | 1.604 | 0.020 | 1.26% | 1.584 | 1.644 | 1.554 |
| Jan 29, 2025 | 1.574 | -0.050 | -3.08% | 1.624 | 1.634 | 1.534 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Aytu BioScience, Inc. Company profile
About Aytu Biopharma Inc
Aytu Biopharma, Inc., formerly Aytu BioScience, Inc., is a specialty pharmaceutical company. The Company markets a portfolio of prescription products addressing primary care and pediatric markets. The Company's primary prescription products treat attention deficit hyperactivity disorder (ADHD) and other common pediatric conditions. It markets ADHD products Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets, Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets, and Adzenys-ER (amphetamine) extended-release oral suspension. The Company's other pediatric products include Karbinal ER (carbinoxamine maleate), an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary fluoride-based prescription vitamin product lines containing combinations of fluoride and vitamins in formulations for infants and children with fluoride deficiency.
Financial summary
BRIEF: For the six months ended 31 December 2021, Aytu Biopharma Inc revenues increased 57% to $45M. Net loss increased from $13.8M to $39.4M. Revenues reflect United States segment increase of 69% to $43.7M. Basic Earnings per Share excluding Extraordinary Items decreased from -$1.07 to -$1.53.
Equity composition
Common Stock no Par, 11/11, 30M auth., 4,774,568 issd. Insiders own 66.98%. 06/15, 1-for-12.174, Reverse Stock Split.
| Industry: | Pharmaceuticals (NEC) |
7900 E. Union Avenue
Suite 920
DENVER
COLORADO 80237
US
News
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com